EGFR and metabolic dysfunction-associated steatotic liver disease: Collectively, our findings reveal that NAFLD promotes liver metastasis of CRC via enhancing de novo palmitate biosynthesis-induced EGFR palmitoylation and provide a rational therapeutic strategy for liver metastasis in CRC patients with NAFLD.